HIV/AIDS: An Update ________________________________________________________________________
41. In the United States, which of the following is NOT a common AIDS-defining opportunistic disease?
47. All pediatric patients being treated for HIV should have follow-up visits scheduled A) within one to two weeks of initiation of therapy, then every three to four months. B) within one to two months of initiation of therapy, then every six to eight months. C) after six months of initiation of therapy, then annually thereafter. D) after one year of proven adherence to therapy. 48. Approximately what percentage of individuals living with HIV in 2024 were 55 years of age and older? A) Less than 1% B) 9%
A) Candidiasis B) Oral herpes C) Kaposi sarcoma D) Pneumocystis pneumonia
42. Which of the following medications is classified as a protease inhibitor? A) Abacavir
B) Tipranavir C) Enfuvirtide D) Lamivudine
43. For treatment-naïve patients, the initial recommended therapy for HIV is A) three NNRTIs. B) two FIs and an NRTI. C) two PIs and a pharmacokinetic enhancer. D) one INSTI and two NRTIs.
C) 41% D) 75%
49. Individuals at an increased risk of acquiring HIV who are good candidates for pre-exposure prophylaxis (PrEP) include sexually active individuals that have had anal or vaginal sexual contact in the past six months, in addition to which of the following? A) Having an HIV-positive sexual partner B) Having a bacterial STI in the past six months C) A history of inconsistent or no condom use with sexual partners D) All of the above
44. The preferred treatment for opportunistic coccidioidomycosis in patients with HIV is A) fluconazole 400 mg daily. B) voriconazole 200 mg daily. C) revaccination with a second vaccine series. D) one dose of benzathine penicillin G 2.4 million units IM. 45. Among Black women 25 to 34 years of age in the United States, HIV/AIDS is A) the leading cause of death. B) the ninth leading cause of death.
50. What proportion of adolescents report having received education on HIV prevention in school?
A) 45% B) 66% C) 84% D) 99%
C) the twentieth leading cause of death. D) not a significant cause of mortality.
46. All of the following are gender-specific
manifestations of HIV in women, EXCEPT: A) Cervical cancer B) Oral hairy leukoplakia C) Recurrent vulvovaginal candidiasis D) Human papillomavirus-related cervical dysplasia
Course Code: MDCT05HA
57
MDCT2026
Powered by FlippingBook